Chemical investigation on the whole plant of Houttuynia cordata has resulted in the isolation of two new compounds, named as houttuynoside A (1) and houttuynamide A (2), together with thirty-eight known compounds. The structures of 1 and 2 were elucidated on the basis of spectroscopic analysis. In the inhibitory effects on herpes simplex virus type 1 (HSV-1) assay, norcepharadione B (10) showed good inhibitory activity against the replication of HSV-1. In addition, the antioxidant and antityrosinase activities of some isolated compounds were also evaluated. Among these compounds, quercitrin (25) 
Houttuynia cordata THUNB. (Saururaceae) is a native perennial herbaceous plant in the eastern and southern regions of Asia. Recently, H. cordata has been used for the treatment of herpes simplex virus type 1 (HSV-1), influenza virus, human immunodeficiency virus type 1 (HIV-1), 1) and chronic sinusitis and nasal polyps.
2) Besides, the whole plant has also been reported to have the antileukemic activity, 3) anticancer activity, 4) adjuvanticity, 5) antioxidant action, 6) and inhibitory effects on anaphylactic reaction and mast cell activation.
2) In our continuing research for bioactive compounds from medicinal plants, this paper deals with isolation, structure elucidation of the new compounds, and evaluation of the anti-herpes simplex virus activity 1 (HSV-1), the antioxidant, and antityrosinase activities of the isolated compounds.
Results and Discussion
The MeOH extract of H. cordata was partitioned with CHCl 3 and H 2 O. The condensed chloroform extract was portioned with n-hexane and 80% CH 3 OH aq . The H 2 O-soluble portion was further portioned with n-BuOH to give a dark brown syrup. Through the further isolation of the subfractions, it led to two new compounds and thirty-eight known compounds.
Houttuynoside A (1) was isolated as optically active colorless syrup. The HR-FAB-MS of 1 exhibited a pesudomolecular ion peak at m/z 451.1244, consistent with the molecular formula C 21 6 Hz, H-3Ј, -5Ј); d C 116.5 (C-3Ј, -5Ј), 130.1 (C-2Ј, -6Ј), 131.5 (C-1Ј) and 156.9 (C-4Ј)] to which is attached a -CH 2 CH 2 N-group as evidenced by HMBC correlations from H-7Ј to C-2Ј, C-6Ј and C-8Ј. These data indicated these two phenyl ring moieties were connected through -CH 2 CH 2 NHCO-linkage.
From the above spectroscopic data, the structure of 2 was determined and named as houttuynamide A.
In addition, thirty-eight known compounds were identified by comparison of their physical and spectroscopic data with those of corresponding authentic samples or literature values. These compounds are aristolactams 3-6 [aristolactam A II (3), 7) aristolactam B II (4), 7) piperolactam A (5), 8 ) and 3,4-dimethoxy-N-methyl aristolactam (6)], 9) oxoaporphines 7 and 8 [splendidine (7) 1) and lysicamine (8)], 10) 4,5-dioxoaporphines 9-11 [cepharadione B (9), 8) norcepharadione B (10), 8) and noraritolodione (11)], 1) amides 12-18 [N-(1-hydroxymethyl-2-phenylethyl)benzamide (12), 11) N-(4-hydroxyphenylethyl)benzamide (13), 12) benzamide (14), 13) 4-hydroxybenzamide (15), 14) 4-hydroxy-3-methoxybenzamide (16), 15) 6,7-dimethyl-1-ribitol-1-yl-1,4-dihydroquinoxaline-2,3-dione (17), 16) and (1H)-quinolinone (18) 19) dehydrovomifoliol (21), 20) reseoside (22), 21) 7-(3,5,6-trihydroxy-2,6,6-trimethylcyclohexyl)-byt-3-en-2-one (23), 22) and 6-(9-hydroxy-but-7-ethyl)-1,1,5-trimethylcyclohexane-3,5,6-triol (24)], 23) flavonoids 25-27 [quercitrin (25) , 24) quercetin-3-O-b-D-galactopyranoside (26), 24) and afzelin (27) ], 24) benzenoids 28-37 [vanillic acid (28), 25) methyl vanillate (29), 26) vanillin (30), 26) protocatechuic acid (31), 27) 4-hydroxybenzoic acid (32), 28) methylparaben (33), 29) p-hydroxybenzaldehyde (34), 30) cis and trans-methyl ferulate (35, 36), 31) and benzyl-b-D-glucopyranoside (37)], 32) steroids 38 and 39 [b-sitosteryl glucoside (38) 33) and b-sitosterol (39)], 25) as well as a triterpenoid 40 [cycloart-25-ene-3b,24-diol (40)]. 34) Inhibitory effects of isolated compounds 3-5, 9-11, 14, 22, 23, 25, 27, 28, 31, 32, 37, and 40 on herpes simplex virus type 1 (HSV-1) replication were investigated as compared with acyclovia. As shown in Table 1 , norcepharadione B (10) significantly suppressed HSV-1 replication by 46.38Ϯ1.06% at the concentration of 100 mM. Compounds 5, 22, and 27 showed moderate activities with inhibition percentages 20.48Ϯ0.00%, 20.45Ϯ1.76%, and 25.44Ϯ1.76%, respectively. Hence, suppression of viral replication of norcepharadione B (10) might have an important implication for H. cordata therapeutic activity in virus infection. In addition, the isolated compounds 15, 16, 25-28, 30, 31, and 33 were also examined for their antioxidant properties using the 2,2-diphenyl-1-picrylhydrazyl free radical (DPPH) assay in Table  2 . Compounds 25, 26, and 31 were found to be active at 250 mM with inhibition percentages 84%, 82%, and 50%, respectively. Quercitrin (25) and quercetin-3-O-b-D-galactopyranoside (26) exhibited strong scavenging activity with IC 50 values of 31 and 63 mM, respectively, which was compared to the reference compound of vitamin E (IC 50 , 80 mM). The antityrosinase activities of 3, 4, 9, 10, 15, 29, and 34 were also evaluated. Among these compounds, cepharadione B (9) exhibited strong inhibitory activity with an IC 50 value of 170 mM, compared to the reference compound of kojic acid (IC 50 value 160 mM).
Experimental
General Melting points were determined using Yanagimoto MP-S3 micro melting point apparatus and were uncorrected. Optical rotations were measured using a JASCO DIP-370 digital polarimeter. UV spectra were recorded on a Hitachi U-3210 spectrophotometer, and IR spectra were recorded on a Shimadzu FT-IR Prestige-21 spectrophotometer.
1 H-and 13 C-NMR, COSY, HMQC, HMBC, and NOESY spectra were recorded on Bruker AVANCE-300, 500 and AMX-400 spectrometers, using tetramethylsilane (TMS) as internal standard. Standard pulse sequences and parameters were used for the NMR experiments and all chemical shifts are reported in parts per million (ppm, d). FAB-MS were obtained on a JEOL JMS-700 spectrometer, and EI-MS were obtained on a VG-70-250S spectrometer.
Column chromatography was performed on silica gel (70-230 mesh, 230-400 mesh). Fractions were monitored by TLC (Merck precoated Si gel 60 F254 plates), using UV light. TLC was conducted on precoated Kieselgel 60 F 254 plates (Merck) and the spots were detected either by examining the plates under a UV lamp or by treating the plates with a 10% methanolic solution of p-anisaldehyde acid followed by heating at 110°C. Plant Materials The whole plant of H. cordata was collected in Taiwan on July in 2004. The plant material was identified and authenticated by Prof. C. S. Kuoh. A voucher specimen (HC04023) has been deposited in the herbarium of National Cheng Kung University, Tainan, Taiwan.
Extraction and Isolation The air-dried and powdered whole plant of H. cordata (9.4 kg) was extracted with hot MeOH (6ϫ20 l) and concentrated under reduced pressure to obtain a dark crude extract (810 g). Then it was suspended in H 2 O and partitioned with CHCl 3 to afford CHCl 3 -(440 g) and H 2 O-soluble portions (360 g), respectively. The condensed chloroform extract was portioned with n-hexane and 80% CH 3 OH aq . The H 2 O-soluble portions was further portioned with n-BuOH to give a dark brown syrup (100 g).
The n-hexane layer was concentrated under reduced pressure to afford a brown syrup (320 g), which was chromatographed on silica gel using gradients of n-hexane and ethyl acetate to give six fractions. Fraction 2 was rechromatographed on silica gel using n-hexane-ethyl acetate (29 : 1 to 0 : 1) as step gradients as eluents to obtain 40 (6.7 mg). Fraction 3 on column chromatography over silica gel using stepwise gradients of n-hexane-ethyl acetate (18 : 1 to 0 : 1) afforded the colorless crystal 39 (1.1 g). Fraction 4 was rechromatographed on a silica gel column with n-hexane-CHCl 3 (2 : 1) as step gradient mixtures to yield 6 (7.8 mg).
The 80% CH 3 OH layer was concentrated and treated with 2% HCl and 1228 Vol. 57, No. 11 (18 g) was chromatographed on a silica gel column eluting with step gradients of CHCl 3 -CH 3 OH (99 : 1 to 0 : 1) as eluents to give nine fractions. Fraction 2 was separated on a silica gel column chromatography and further purified by preparative TLC with nhexane-ethyl acetate (9 : 1) to obtain 29 (2.3 mg) and 30 (1.2 mg). Purification of fraction 6 on a silica gel column chromatography eluting with a step gradient of diisopropyl ether-ethyl acetate (14 : 1 to 1 : 1) as eluents and further separated by preparative TLC to obtain 34 (0.9 mg). Fraction 7 was subjected to column chromatography over a silica gel using a stepwise gradient of n-hexane-ethyl acetate (1 : 1 to 0 : 1) as eluents and then was further purified on the chromatography to afford 7 (1.8 mg) and 21 (1.2 mg). Purification of the fraction 8 by silica gel with n-hexane-ethyl acetate (1 : 1 to 0 : 1) as step gradient mixtures as eluents and then purified by preparative thinlayer chromatography with CHCl 3 -MeOH (9 : 1) to afford 15 (2.1 mg), 31 (2.5 mg), and 28 (2.4 mg).
The n-BuOH layer (100 g) was chromatographed over reversed-phase Diaion HP-20 gel using H 2 O-CH 3 OH as step gradients, and afforded seven fractions. Fraction 2 was subjected to silica gel column chromatography using diisopropyl ether-CH 3 OH (5 : 1 to 0 : 1) as step gradient mixtures as eluents to afford 19 (7.5 mg). Fraction 3 was purified on a silica gel column using CHCl 3 -CH 3 OH (7 : 1) as step gradients as eluent to yield 32 (1.7 mg). Fraction 4 was separated on a silica gel column chromatography with CHCl 3 -CH 3 OH-H 2 O (5 : 1 : 0.1) and further purified by preparative TLC to obtain successively 17 (2.0 mg), 22 (4.2 mg), 23 (5.2 mg), 24 (3.0 mg) and 37 (6.0 mg). Fraction 5 was separated using a silica gel column with step gradients of diisopropyl ether-CH 3 OH-H 2 O (5 : 1 : 0.1 to 0 : 1 : 0.1) as eluent to give four fractions. Fraction 5-2 occurring the white precipitate was recrystallized by CH 3 OH to yield 26 (0.9 g). The subfraction 5-3 was separated on a silica gel column chromatography and further purified by preparative TLC with CHCl 3 -CH 3 OH-H 2 O (7 : 1 : 0.1) to give 14 (1.8 mg), 20 (1.9 mg), and 2 (2.3 mg). Fraction 6 was subjected to column chromatography over a silica gel using stepwise gradients of diisopropyl ether-CH 3 Cell Culture and Viruses Vero cells were cultured in minimal essential medium (MEM; GIBCO, Grand Island, NY, U.S.A.) supplement with 10% fetal calf serum (FCS; Hyclone, Logan, UT, U.S.A.), 100 U/ml penicillin, and 100 mg/ml streptomycin and incubated at 37°C in a 5% CO 2 incubator. To prepare HSV-1 (KOS strain, VR-1493, ATCC) stocks, Vero cells were infected by HSV-1 at a multiplicity of infection (m.o.i.) of 3 plaque forming units (PFU)/cell and harvested at 24 h postinfection and centrifuged at 1500ϫg (Centrifuge 5810 R, Eppendorf) at 4°C for 20 min. The supernatant was collected and stored at Ϫ70°C for use.
Plaque Reduction Assay The assay followed procedures described previously. 35) Vero cells (3.5ϫ10 5 /dish) were overlaid with test compounds (100 mM) and 100 plaque forming units (PFU) of HSV-1 were added to each dish. The viruses were adsorbed for 1 h at 37°C and 1% methylcellulose was added to each well. After 5 d, the virus plaques formed in Vero cells were counted by crystal violet staining. The activities of test compounds and acyclovir for inhibition of plaque formation were calculated.
Antioxidant Assay The antioxidant assay was based on methods reported by Mellors and Tappel. 36) The percentage values of inhibition were recorded after incubating for 30 min.
Antityrosinase Assay The antityrosinase assay was based on the method of Bernard and Berthon. 37) 
